ArticleCureus2025
Behavior Changes of Patients With Type 2 Diabetes During the National Lockdown Due to the COVID-19 Pandemic.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe previously reported that the national lockdown led to worsening glucose control and increased systolic blood pressure in patients with type 2 diabetes (T2D). This study aimed to investigate the impact of the national lockdown on changes in diet and physical activity among these patients.
methodsA questionnaire-based survey (N=100) was conducted to assess changes in dietary habits, physical activity, and medication adherence during the lockdown in a subset of patients from the Siriraj Diabetes Registry who attended a follow-up visit after the lockdown.
resultsThe mean age of the participants was 60.3 ± 11.9 years, with 60% being female. Of 100 patients, changes in dietary patterns and physical activity were reported in 38 (38%) and 25 (25%) of patients, respectively. Self-reported weight gain occurred in 25 (25%) of participants. Medication adherence for anti-diabetic drugs, anti-hypertensive drugs, and lipid-lowering agents remained high, with 80 (80%) of patients reporting good compliance (defined as taking >80% of prescribed medications). No significant differences in medication adherence were observed during or after the lockdown compared to pre-lockdown levels.
conclusionsThe COVID-19 national lockdown in Thailand led to notable changes in dietary habits and physical activity among patients with T2D. However, medication adherence remained stable throughout the lockdown period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.